Drugs / AG23041
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06916169 | Aug → Sep 2025 overdue | — | Ahn-Gook Pharmaceuticals Co.,Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AG23041 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06916169 ↗ |
| Route | Oral | “AG23041/AG23042, Single-dose Oral Administration” NCT06916169 ↗ |